MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. (clinicaltrials.gov) - Oct 14, 2026 - P2 | N=108 | Recruiting | Sponsor: Swiss Cancer Institute | Not yet recruiting ➔ Recruiting
Enrollment open • Tumor mutational burden • Melanoma • Oncology • Solid Tumor
|